Among these 45 patients, 11 out of the 16 with diffuse tumours fulfilled the HDGC criteria for testing the CDH1/CTNNA1 genes, and two of these 11 also fulfilled the criteria for Lynch syndrome (both with a pathogenic variant in the MLH1 gene). This evidence concerns the gene MLH1 and Lynch syndrome.